| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1044009729 |
| P356 | DOI | 10.1186/AR2099 |
| P932 | PMC publication ID | 1794533 |
| P698 | PubMed publication ID | 17177994 |
| P5875 | ResearchGate publication ID | 6622188 |
| P50 | author | Jan Bondeson | Q455303 |
| Clare E. Hughes | Q46565033 | ||
| P2093 | author name string | Sarah Lauder | |
| Shane D Wainwright | |||
| Nick Amos | |||
| P2860 | cites work | Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins | Q22009926 |
| Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family | Q22010479 | ||
| Mechanisms involved in cartilage proteoglycan catabolism | Q30653137 | ||
| Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. | Q30807179 | ||
| Cytokine production in culture by cells isolated from the synovial membrane | Q69229748 | ||
| CD45-induced tumor necrosis factor alpha production in monocytes is phosphatidylinositol 3-kinase-dependent and nuclear factor-kappaB-independent | Q73176074 | ||
| Usefulness of high resolution US in the evaluation of effusion in osteoarthritic first carpometacarpal joint | Q74011868 | ||
| Development of anti-TNF therapy for rheumatoid arthritis | Q74187188 | ||
| The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation | Q74419209 | ||
| C-reactive protein as a biomarker of emergent osteoarthritis | Q78649895 | ||
| Induction of aggrecanase 1 (ADAM-TS4) by interleukin-1 occurs through activation of constitutively produced protein | Q78794868 | ||
| Macroscopic and microscopic features of synovial membrane inflammation in the osteoarthritic knee: correlating magnetic resonance imaging findings with disease severity | Q81412996 | ||
| Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study | Q81922681 | ||
| Pathologic indicators of degradation and inflammation in human osteoarthritic cartilage are abrogated by exposure to n-3 fatty acids. | Q30836366 | ||
| Catabolism of aggrecan, decorin and biglycan in tendon. | Q30894356 | ||
| Effects of intraarticular glucocorticoids on macrophage infiltration and mediators of joint damage in osteoarthritis synovial membranes: findings in a double-blind, placebo-controlled study | Q32067927 | ||
| An alternative spliced transcript of ADAMTS4 is present in human synovium from OA patients | Q33244618 | ||
| Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis | Q33565984 | ||
| Design and synthetic considerations of matrix metalloproteinase inhibitors | Q33692904 | ||
| Clinical trials of a stromelysin inhibitor. Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications | Q33692920 | ||
| Cytokines and their role in the pathophysiology of osteoarthritis | Q33753628 | ||
| Degradative enzymes in osteoarthritis. | Q33753639 | ||
| The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models | Q33894450 | ||
| Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets | Q34283578 | ||
| Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis | Q34407611 | ||
| ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro | Q34407615 | ||
| Anticytokine therapy for osteoarthritis | Q34452635 | ||
| The role of cytokines in osteoarthritis pathophysiology | Q34524517 | ||
| Increased serum C reactive protein may reflect events that precede radiographic progression in osteoarthritis of the knee | Q35548883 | ||
| Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. | Q35549401 | ||
| Synovial macrophage-osteoclast differentiation in inflammatory arthritis | Q35551058 | ||
| Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent | Q36172262 | ||
| Lessons learned from nine clinical trials of disease-modifying osteoarthritis drugs | Q36301297 | ||
| Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators | Q36364193 | ||
| Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? | Q40684838 | ||
| Cytokine inducible matrix metalloproteinase expression in immortalized rat chondrocytes is independent of nitric oxide stimulation | Q41031027 | ||
| Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade | Q42956113 | ||
| Synovial tissue inflammation in early and late osteoarthritis | Q43048512 | ||
| Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis | Q43873302 | ||
| Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis | Q44064388 | ||
| Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro | Q44183277 | ||
| Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation | Q44733622 | ||
| Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis | Q44985215 | ||
| Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice | Q45034879 | ||
| Rapid isolation of total RNA from small samples of hypocellular, dense connective tissues. | Q48049317 | ||
| Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IkappaBalpha reveals that most, but not all, inflammatory and destructive mediators are NFkappaB dependent. | Q50735189 | ||
| Adenoviral gene transfer of the endogenous inhibitor IkappaBalpha into human osteoarthritis synovial fibroblasts demonstrates that several matrix metalloproteinases and aggrecanases are nuclear factor-kappaB-dependent | Q57539923 | ||
| Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: The Johnston county osteoarthritis project | Q57721652 | ||
| Inflammation and angiogenesis in osteoarthritis | Q59151152 | ||
| High resolution ultrasonography in detection of bone erosions in patients with hand osteoarthritis | Q59536393 | ||
| Heterogeneous requirement of IkappaB kinase 2 for inflammatory cytokine and matrix metalloproteinase production in rheumatoid arthritis: implications for therapy | Q60169453 | ||
| ??? | Q28371140 | ||
| P433 | issue | 6 | |
| P921 | main subject | osteoarthritis | Q62736 |
| macrophage | Q184204 | ||
| P304 | page(s) | R187 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis | |
| P478 | volume | 8 |
| Q35028071 | A 3D cartilage - inflammatory cell culture system for the modeling of human osteoarthritis |
| Q39355336 | A Brief History of IL-1 and IL-1 Ra in Rheumatology |
| Q38812043 | A Three-Dimensional Chondrocyte-Macrophage Coculture System to Probe Inflammation in Experimental Osteoarthritis |
| Q34205901 | ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis |
| Q90092773 | Acute Synovitis after Trauma Precedes and is Associated with Osteoarthritis Onset and Progression |
| Q28541499 | Adiponectin enhances intercellular adhesion molecule-1 expression and promotes monocyte adhesion in human synovial fibroblasts |
| Q53306751 | Advanced glycation end-products induced VEGF production and inflammatory responses in human synoviocytes via RAGE-NF-κB pathway activation. |
| Q35740486 | Analgesic and anti-Inflammatory effect of UP3005, a botanical composition Containing two standardized extracts of Uncaria gambir and Morus alba |
| Q42089366 | Andrographolide Exerts Chondroprotective Activity in Equine Cartilage Explant and Suppresses Interleukin-1 β -Induced MMP-2 Expression in Equine Chondrocyte Culture. |
| Q41261105 | Anti-inflammatory activity of an ethanolic Caesalpinia sappan extract in human chondrocytes and macrophages. |
| Q89576233 | Anti-inflammatory effects of naproxen sodium on human osteoarthritis synovial fluid immune cells |
| Q39906208 | Anticytokine therapy for osteoarthritis: evidence to date |
| Q38557650 | Applying nanomedicine in maladaptive inflammation and angiogenesis |
| Q37956680 | Are we moving in the right direction with osteoarthritis drug discovery? |
| Q33706444 | Arthroscopic assessment of stifle synovitis in dogs with cranial cruciate ligament rupture |
| Q45958433 | Assessment of pain-related behavior and pro-inflammatory cytokine levels in the rat rotator cuff tear model. |
| Q35199091 | Autologous processed plasma: cytokine profile and effects upon injection into healthy equine joints. |
| Q54895179 | Biochemical Response to a Moderate Running Bout in Participants With or Without a History of Acute Knee Injury. |
| Q35092924 | Bone resorption and remodeling in murine collagenase-induced osteoarthritis after administration of glucosamine |
| Q53604587 | CD11c(+) macrophages and levels of TNF-α and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidaemia. |
| Q37782019 | Cartilage biology, pathology, and repair. |
| Q49169602 | Cell-type-specific gene expression patterns in the knee cartilage in an osteoarthritis rat model. |
| Q36793110 | Characterisation of synovial fluid and infrapatellar fat pad derived mesenchymal stromal cells: The influence of tissue source and inflammatory stimulus. |
| Q30386272 | Characterizing heterogeneity in the response of synovial mesenchymal progenitor cells to synovial macrophages in normal individuals and patients with osteoarthritis |
| Q37689660 | Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis |
| Q37251402 | Chondroprotective effect of high-molecular-weight hyaluronic acid on osteoarthritic chondrocytes in a co-cultivation inflammation model with M1 macrophages |
| Q28513228 | Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity |
| Q33876517 | Coculture of bovine cartilage with synovium and fibrous joint capsule increases aggrecanase and matrix metalloproteinase activity |
| Q37300823 | Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis |
| Q35029264 | Comparative analysis of two low-level laser doses on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation |
| Q93272663 | Comparison of early-stage changes of osteoarthritis in cartilage and subchondral bone between two different rat models |
| Q50979968 | Conditional Macrophage Depletion Increases Inflammation and Does Not Inhibit the Development of Osteoarthritis in Obese Macrophage Fas-Induced Apoptosis-Transgenic Mice. |
| Q34035809 | Control of cell migration and inflammatory mediators production by CORM-2 in osteoarthritic synoviocytes |
| Q52915498 | Cricoarytenoid Articulation in Elderly Japanese With Special Reference to Morphology of the Synovial Tissue. |
| Q34283216 | Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi |
| Q37331102 | Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism |
| Q50879036 | Delivery of anti-inflammatory peptides from hollow PEGylated poly(NIPAM) nanoparticles reduces inflammation in an ex vivo osteoarthritis model. |
| Q54192438 | Depletion of protease-activated receptor 2 but not protease-activated receptor 1 may confer protection against osteoarthritis in mice through extracartilaginous mechanisms. |
| Q34727681 | Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era |
| Q38809643 | Direct in vivo evidence of activated macrophages in human osteoarthritis |
| Q34677275 | Diverse expression of selected cytokines and proteinases in synovial fluid obtained from osteoarthritic and healthy human knee joints |
| Q37199641 | Drug insight: aggrecanases as therapeutic targets for osteoarthritis. |
| Q28580263 | Effect of low-level laser therapy on the expression of inflammatory mediators and on neutrophils and macrophages in acute joint inflammation |
| Q41980295 | Effect of two different preparations of platelet-rich plasma on synoviocytes |
| Q34331057 | Effects of CD14 macrophages and proinflammatory cytokines on chondrogenesis in osteoarthritic synovium-derived stem cells |
| Q47252649 | Effects of sesamin on primary human synovial fibroblasts and SW982 cell line induced by tumor necrosis factor-alpha as a synovitis-like model |
| Q42612506 | Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts |
| Q36975912 | Engineering of functional cartilage tissue using stem cells from synovial lining: a preliminary study |
| Q84866017 | Evaluation of cartilage degradation in arthritis using T1ρ magnetic resonance imaging mapping |
| Q33612450 | Evaluation of serum chondroitin sulfate and hyaluronan: biomarkers for osteoarthritis in canine hip dysplasia |
| Q55551696 | Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy. |
| Q41485875 | Exploratory secondary analyses of a cognitive-behavioral intervention for knee osteoarthritis demonstrate reduction in biomarkers of adipocyte inflammation |
| Q64110939 | Exploring the Involvement of NLRP3 and IL-1 in Osteoarthritis of the Hand: Results from a Pilot Study |
| Q35846285 | Expression analysis of the osteoarthritis genetic susceptibility locus mapping to an intron of the MCF2L gene and marked by the polymorphism rs11842874. |
| Q80380416 | Expression profiling of select cytokines in canine osteoarthritis tissues |
| Q46044165 | Extracorporeal Shockwave Therapy Enhances Expression of Pdia-3 Which Is a Key Factor of the 1α,25-Dihydroxyvitamin D 3 Rapid Membrane Signaling Pathway in Treatment of Early Osteoarthritis of the Knee |
| Q36347326 | FOXO1, PXK, PYCARD and SAMD9L are differentially expressed by fibroblast-like cells in equine synovial membrane compared to joint capsule. |
| Q36765451 | From osteoarthritic synovium to synovial-derived cells characterization: synovial macrophages are key effector cells. |
| Q42708538 | Genetic and cellular evidence of decreased inflammation associated with reduced incidence of posttraumatic arthritis in MRL/MpJ mice |
| Q30355663 | Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases. |
| Q48140227 | Glucosamine oral administration as an adjunct to hyaluronic acid injection in treating temporomandibular joint osteoarthritis |
| Q34153150 | High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes |
| Q26800733 | High systemic levels of low-density lipoprotein cholesterol: fuel to the flames in inflammatory osteoarthritis? |
| Q48132370 | Histomorphology and innate immunity during the progression of osteoarthritis: Does synovitis affect cartilage degradation? |
| Q41044055 | IL-37 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells |
| Q33799161 | IL-6 secretion in osteoarthritis patients is mediated by chondrocyte-synovial fibroblast cross-talk and is enhanced by obesity |
| Q47387015 | Imaging of Folate Receptor Expressing Macrophages in the Rat Groove Model of Osteoarthritis: Using a New DOTA-Folate Conjugate |
| Q37170273 | Immediate Administration of Intraarticular Triamcinolone Acetonide After Joint Injury Modulates Molecular Outcomes Associated With Early Synovitis |
| Q51379645 | Immunohistochemical analysis of the effects of estrogen on intraarticular neurogenic inflammation in a rat anterior cruciate ligament transection model of osteoarthritis. |
| Q33587966 | Immunopathogenesis of osteoarthritis |
| Q38027919 | Impact of inflammation on the osteoarthritic niche: implications for regenerative medicine. |
| Q33410403 | In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage |
| Q37690510 | Increased physical activity severely induces osteoarthritic changes in knee joints with papain induced sulfate-glycosaminoglycan depleted cartilage |
| Q48155412 | Indication for joint replacement and glutathione s-transferases M1 and T1 genotypes. |
| Q36242268 | Inflammatory biomarkers in osteoarthritis |
| Q55076032 | Inflammatory pattern of the infrapatellar fat pad in dogs with canine cruciate ligament disease. |
| Q59645698 | Inflammatory response in patients with active and inactive osteoarthritis |
| Q51764602 | Interaction with macrophages attenuates Equine Fibroblast-Like Synoviocyte ADAMTS5 (aggrecanase-2) gene expression following inflammatory stimulation. |
| Q36346952 | Intersection of inflammation and herbal medicine in the treatment of osteoarthritis |
| Q38597565 | Investigational drugs for the treatment of osteoarthritis |
| Q23914570 | Joint inflammation and early degeneration induced by high-force reaching are attenuated by ibuprofen in an animal model of work-related musculoskeletal disorder |
| Q81217971 | Lessons from animal models of osteoarthritis |
| Q52584284 | Macrophages and bone inflammation. |
| Q89687551 | Macrophages in osteoarthritis: pathophysiology and therapeutics |
| Q38822218 | Management of knee osteoarthritis. Current status and future trends |
| Q38317248 | Matrix-embedded cytokines to simulate osteoarthritis-like cartilage microenvironments |
| Q38270933 | Mechanically induced experimental knee osteoarthritis benefits from anti-inflammatory and immunomodulatory properties of simvastatin via inhibition of matrix metalloproteinase-3 |
| Q38245619 | Mechanisms of post-traumatic osteoarthritis after ACL injury |
| Q53362172 | Mechano growth factor-E regulates apoptosis and inflammatory responses in fibroblast-like synoviocytes of knee osteoarthritis. |
| Q47136831 | Mesenchymal Stem Cells for Cartilage Regeneration of TMJ Osteoarthritis. |
| Q36876612 | MicroRNA-33 suppresses CCL2 expression in chondrocytes |
| Q98771789 | MicroRNAs in Synovial Pathology Associated With Osteoarthritis |
| Q38138598 | New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine? |
| Q38424856 | Novel Insights into Osteoarthritis Joint Pathology from Studies in Mice. |
| Q89576490 | Ontology and Function of Fibroblast-Like and Macrophage-Like Synoviocytes: How Do They Talk to Each Other and Can They Be Targeted for Rheumatoid Arthritis Therapy? |
| Q26849681 | Osteoarthritis pain mechanisms: basic studies in animal models |
| Q37891476 | Osteoarthritis: an update with relevance for clinical practice |
| Q37682714 | Osteoarthritis: can anti-cytokine therapy play a role in treatment? |
| Q57288028 | Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development |
| Q40117963 | Periodontitis, pathogenesis and progression: miRNA-mediated cellular responses to Porphyromonas gingivalis |
| Q39416382 | Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. |
| Q101133269 | Preparation and characterization of amnion hydrogel and its synergistic effect with adipose derived stem cells towards IL1β activated chondrocytes |
| Q84014169 | Pulsed electromagnetic fields decrease proinflammatory cytokine secretion (IL-1β and TNF-α) on human fibroblast-like cell culture |
| Q35242231 | Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis |
| Q36212495 | Radiological and biochemical effects (CTX-II, MMP-3, 8, and 13) of low-level laser therapy (LLLT) in chronic osteoarthritis in Al-Kharj, Saudi Arabia. |
| Q38861162 | Recent advances in the understanding of molecular mechanisms of cartilage degeneration, synovitis and subchondral bone changes in osteoarthritis |
| Q47340412 | Role of CD44 in Regulating TLR2 Activation of Human Macrophages and Downstream Expression of Proinflammatory Cytokines |
| Q36800978 | Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations |
| Q37814044 | Role of proinflammatory cytokines in the pathophysiology of osteoarthritis |
| Q35933890 | Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health |
| Q51278598 | Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis. |
| Q33766376 | Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes |
| Q50955893 | Single intra-articular injection of fluvastatin-PLGA microspheres reduces cartilage degradation in rabbits with experimental osteoarthritis. |
| Q37412497 | Suppression of aggrecanase: a novel protective mechanism of dehydroepiandrosterone in osteoarthritis? |
| Q93016750 | Synovial Cytokines Significantly Correlate with Osteoarthritis-Related Knee Pain and Disability: Inflammatory Mediators of Potential Clinical Relevance |
| Q53340014 | Synovial macrophage-derived IL-1β regulates the calcitonin receptor in osteoarthritic mice. |
| Q34572095 | Synoviocytes protect cartilage from the effects of injury in vitro |
| Q39844159 | Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis |
| Q100634898 | TAP2, a peptide antagonist of Toll-like receptor 4, attenuates pain and cartilage degradation in a monoiodoacetate-induced arthritis rat model |
| Q61051844 | Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer |
| Q30277841 | Targeting formyl peptide receptor 1 of activated macrophages to monitor inflammation of experimental osteoarthritis in rat. |
| Q47566502 | The Absence of Detectable ADAMTS-4 (Aggrecanase-1) Activity in Synovial Fluid Is a Predictive Indicator of Autologous Chondrocyte Implantation Success |
| Q52902373 | The Expression of Proinflammatory Cytokines and Matrix Metalloproteinases in the Synovial Membranes of Patients With Osteoarthritis Compared With Traumatic Knee Disorders |
| Q55025580 | The IL-1β/AP-1/miR-30a/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis. |
| Q34027506 | The association between leptin, interleukin-6, and hip radiographic osteoarthritis in older people: a cross-sectional study |
| Q33651884 | The autocrine role of proteoglycan-4 (PRG4) in modulating osteoarthritic synoviocyte proliferation and expression of matrix degrading enzymes |
| Q37315643 | The complement system is activated in synovial fluid from subjects with knee injury and from patients with osteoarthritis. |
| Q28251734 | The contribution of the synovium, synovial derived inflammatory cytokines and neuropeptides to the pathogenesis of osteoarthritis |
| Q33580809 | The cytokine expression in synovial membrane and the relationship with pain and pathological findings at hip arthroscopy |
| Q91722324 | The exosome-like vesicles from osteoarthritic chondrocyte enhanced mature IL-1β production of macrophages and aggravated synovitis in osteoarthritis |
| Q34709647 | The fluence effects of low-level laser therapy on inflammation, fibroblast-like synoviocytes, and synovial apoptosis in rats with adjuvant-induced arthritis |
| Q37825835 | The role of ADAMTSs in arthritis |
| Q33614316 | The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. |
| Q38320224 | The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive |
| Q37798162 | The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis |
| Q38594372 | Therapeutic application of mesenchymal stem cells in osteoarthritis. |
| Q47978774 | Tocilizumab (Actemra). |
| Q94554568 | Transcriptional profiling of murine macrophages stimulated with cartilage fragments revealed a strategy for treatment of progressive osteoarthritis |
| Q33861852 | Transforming growth factor activating kinase 1 regulates extracellular matrix degrading enzymes and pain-related molecule expression following tumor necrosis factor-α stimulation of synovial cells: an in vitro study |
| Q43429102 | Triterpene acids from rose hip powder inhibit self-antigen- and LPS-induced cytokine production and CD4⁺ T-cell proliferation in human mononuclear cell cultures |
| Q85956608 | Unicompartmental and bicompartmental knee osteoarthritis show different patterns of mononuclear cell infiltration and cytokine release in the affected joints |
| Q34550052 | Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation |
| Q37254897 | Vitamin D attenuates inflammation, fatty infiltration, and cartilage loss in the knee of hyperlipidemic microswine |
| Q36683775 | What is the effect of nicotinic acetylcholine receptor stimulation on osteoarthritis in a rodent animal model? |
Search more.